Interesting science but this is really a stretch over a dime without some really important news...............So two non medical guys own all rights to "formulations" that don't appear to have patents and they plan to out source R&D on these "formulations" and apply for patents as studies advance (assuming success)..........waaay to little information. I think an investor here better be able to sit 3-4 years if they take a position. I like the concept so I'll keep watching and doing my DD before I consider taking a position. Anyone know more about this company than is on their web site or the connection to Kard I'd appreciate your sharing.
Market Data 
Markets 
AI
